Mubadala’s KELIX bio Acquires Four GlobalOne Healthcare Holding Pharma Assets to Strengthen Life Sciences Presence in the UAE
Abu Dhabi: Following the closing of the acquisition of KELIX bio, Mubadala Investment Company PJSC “Mubadala”, an Abu Dhabi sovereign investor, has empowered its new specialty pharmaceutical business to acquire a 100% stake
